Opinion

Video

Future Directions for Type 2 Inflammation Management

Reynold A. Panettieri Jr., MD, examines the application of biologic therapies in the treatment of respiratory conditions.

  • Biologics are currently available for asthma management and being studied in COPD patients. Where do you envision the potential place of biologic therapies in the treatment algorithm for patients with type 2 inflammation-driven COPD?
    • How does the route of administration impact the treatment selection?
  • What emerging therapies for type 2 inflammation related to respiratory diseases are you most excited about? What are clinical trial data showing in terms of exacerbation and hospitalization rates, patient quality of life, and general disease management?
Related Videos
Christine Funke, MD
5 experts are featured in this series
5 experts are featured in this series
1 expert in this video
1 expert in this video
Dr Margrit Wiesendanger
4 experts are featured in this series.
5 experts in this video
4 experts are featured in this series.
5 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo